骨髓间充质干细胞联合肝细胞生长因子基因治疗兔肢体缺血
作者:
通讯作者:
作者单位:

作者简介:

王默 E-mail:doctorwangmo@126.com

基金项目:

山东省优秀博士基金资助项目(2006bs03025;2008bs03011)。


Combination treatment with bone mesenchymal stem cells and HGF gene therapy for limb ischemia of rabbit
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    目的:探讨联合应用骨髓间充质干细胞(BMSC)和肝细胞生长因子(HGF)基因治疗兔肢体缺血的疗效。方法:32只新西兰兔切除右后肢股浅动脉并结扎股深动脉建立后肢缺血模型,成模后随机均分为空腺病毒对照组(对照组),BMSC细胞治疗组(BMSC组),HGF基因治疗组(HGF组)和联合治疗组(BMSC+HGF组),各组均采用术肢肌肉内原位注射。治疗28 d后通过动脉造影行侧枝血管计数,治疗30 d后用免疫组化和Western blot法检测注射点周围组织中CD31和HGF的表达。结果:BMSC组及HGF组的侧支血管计数与对照组间差异无统计学意义,而BMSC+HGF组侧支血管计数较其余各组明显增加(P<0.05或P<0.01);免疫组化显示,各处理组CD31表达量明显高于对照组(P<0.05或P<0.01),BMSC组和HGF组间CD31表达量无明显差异(P>0.05),但两者均明显低于BMSC+HGF组(均P<0.05);Western blot显示,各处理组HGF表达量均高于对照组(P<0.05或P<0.01),且HGF在BMSC组、HGF组和BMSC+HGF组中的表达量依次增高,差异均有统计学意义(均P<0.05)。结论:BMSC联合HGF基因治疗具有协同效应,能有效增加兔缺血肢体的侧枝血管,改善肢体缺血状况。

    Abstract:

    Objective: To investigate the therapeutic effect of the combination treatment of bone mesenchymal stem cells (BMSC) and hepatocyte growth factor (HGF) gene therapy on limb ischemia of rabbits. Methods: Ischemic model of hind limb was induced in the right hind limb of 32 New Zealand rabbits by ligation of the deep femoral artery and complete excision of the superficial femoral artery. After the model was established, the rabbits were equally randomized into empty plasmid treatment group (control group), BMSC treatment group (BMSC group), HGF gene therapy group (HGF group) and BMSC treatment plus HGF gene therapy group (BMSC+HGF group). All treatment regimens were administered by direct intramuscular injection into the operated limb. The collateral vessel count was performed using angiography 28 days after treatment, and the expression of CD31 and HGF in the muscle tissues surrounding the injection sites was detected by immunohistochemical staining and Western blot analysis respectively, 30 days after treatment. Results:The collateral vessel count showed no statistical difference in BMSC group or HGF group compared with control group, but it increased significantly in BMSC+HGF group compared with other 3 groups (P<0.05 or P<0.01). The immunohistochemical staining showed that the CD31 expression level of all the treated groups was significantly higher than that of the control group (P<0.05 or P<0.01), and CD31 expression had no significant difference between BMSC group and HGF group, but both of which were significantly lower than that of BMSC+HGF group (both P<0.05). The Western blot demonstrated that the HGF expression level of all the treated groups was significantly higher than that of the control group (P<0.05 or P<0.01), and it was increased in the order of BMSC, HGF and BMSC+HGF group that all had statistical differences (all P<0.05). Conclusions: The combination treatment with BMSC and HGF gene therapy has synergistic effect that can effectively promote collateral vessel development, and thereby improve the perfusion of the ischemic limb of rabbit.

    参考文献
    相似文献
    引证文献
引用本文

周华|王默|金星|张十一|高斌斌|王茂华.骨髓间充质干细胞联合肝细胞生长因子基因治疗兔肢体缺血[J].中国普通外科杂志,2011,20(12):1342-1346.
DOI:10.7659/j. issn.1005-6947.2011.12.015

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2011-07-07
  • 最后修改日期:2011-11-05
  • 录用日期:
  • 在线发布日期: 2011-12-15